Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy

被引:0
|
作者
Regina Mühleck
Sebastian Scholl
Inken Hilgendorf
Karin Schrenk
Jakob Hammersen
Jochen J. Frietsch
Maximilian Fleischmann
Herbert G. Sayer
Anita Glaser
Andreas Hochhaus
Ulf Schnetzke
机构
[1] Universitätsklinikum Jena,Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie
[2] HELIOS Klinikum Erfurt,4. Medizinische Klinik
[3] Universitätsklinikum Jena,Institut für Humangenetik
关键词
AML; Refractory; Relapse; Salvage therapy; Mito-FLAG;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2539 / 2548
页数:9
相关论文
共 50 条
  • [1] Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy
    Muehleck, Regina
    Scholl, Sebastian
    Hilgendorf, Inken
    Schrenk, Karin
    Hammersen, Jakob
    Frietsch, Jochen J.
    Fleischmann, Maximilian
    Sayer, Herbert G.
    Glaser, Anita
    Hochhaus, Andreas
    Schnetzke, Ulf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (09) : 2539 - 2548
  • [2] Mito-FLAG as salvage therapy for relapsed and refractory acute myeloid leukemia
    Hänel, M
    Friedrichsen, K
    Hänel, A
    Herbst, R
    Morgner, A
    Neser, S
    Nicklisch, M
    Teich, M
    Ehninger, G
    Fiedler, F
    ONKOLOGIE, 2001, 24 (04): : 356 - 360
  • [3] Clinical study of Mito-FLAG regimen in treatment of relapsed acute myeloid leukemia
    Luo, Sheng
    Cai, Fangfang
    Jiang, Lei
    Zhang, Shenghui
    Shen, Zhijian
    Sun, Lan
    Gao, Shenmeng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (03) : 982 - 986
  • [4] The Clinical Outcome of FLAG Chemotherapy without Idarubicin in Patients with Relapsed or Refractory Acute Myeloid Leukemia
    Lee, Se Ryeon
    Yang, Deck Hwan
    Ahn, Jae Sook
    Kim, Yeo Kyeoung
    Lee, Je Jung
    Choi, Young Jin
    Shin, Ho Jin
    Chung, Joo Seop
    Cho, Yoon Young
    Chae, Yee Soo
    Kim, Jong Gwang
    Sohn, Sang Kyun
    Kim, Hyeoung Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (03) : 498 - 503
  • [5] FLAG salvage therapy combined with idarubicin in relapsed/refractory acute myeloid leukemia
    Westhus, Jonas
    Noppeney, Richard
    Duehrsen, Ulrich
    Hanoun, Maher
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1014 - 1022
  • [6] Mito-FLAG (mitoxantrone, fludarabine, Ara-C as bolus or continuous infusion, G-CSF) for relapsed or refractory acute myeloid leukemia.
    Hänel, M
    Friedrichsen, K
    Grundeis, M
    Hänel, A
    Herbst, R
    Morgner, A
    Neser, S
    Teich, M
    Fiedler, F
    BLOOD, 1998, 92 (10) : 216B - 217B
  • [7] Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia
    Mushtaq, Muhammad Umair
    Chaudhary, Sibgha Gull
    Michaelis, Laura C.
    Carlson, Karen-Sue B.
    Abedin, Sameem
    Runass, Lyndsey
    Fallon, Michael J.
    Harrington, Alexandra M.
    Juckett, Mark
    Hall, Aric C.
    Mattison, Ryan J.
    Atallah, Ehab L.
    Murthy, Guru Subramanian Guru
    BLOOD, 2018, 132
  • [8] Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
    Bogdan Popescu
    Sheenu Sheela
    Julie Thompson
    Sophia Grasmeder
    Therese Intrater
    Christin B. DeStefano
    Christopher S. Hourigan
    Catherine Lai
    Clinical Hematology International, 2020, 2 (1) : 27 - 31
  • [9] Outcome of Refractory and Relapsed Patients with Acute Myeloid Leukemia
    Niederwieser, Dietger
    Krahl, Rainer
    Kahle, Christoph
    Scholl, Sebastian
    Wolf, Hans-Heinrich
    Cross, Michael
    Hegenbart, Ute
    Peter, Norma
    Niederwieser, Christian
    Florschuetz, Axel
    Reifenrath, Kolja F. B.
    Zojer, Niklas
    Junghanss, Christian
    Sayer, Herbert
    Schmidt, Volker
    Maschmeyer, Georg
    Hochhaus, Andreas
    Fischer, Thomas
    Al-Ali, Haifa Kathrin
    Heinicke, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 106 - 106
  • [10] Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia
    Westhus, Jonas
    Noppeney, Richard
    Schmitz, Christine
    Flasshove, Michael
    Duehrsen, Ulrich
    Hanoun, Maher
    ACTA HAEMATOLOGICA, 2020, 143 (05) : 438 - 445